Viewing StudyNCT02801097



Ignite Creation Date: 2024-05-06 @ 8:42 AM
Last Modification Date: 2024-10-26 @ 12:04 PM
Study NCT ID: NCT02801097
Status: TERMINATED
Last Update Posted: 2022-05-17
First Post: 2016-06-10

Brief Title: RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer PAYLOAD
Sponsor:
Organization: EpicentRx Inc